Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedC Biopharma is a Canadian clinical-stage biopharmaceutical company developing patented cannabinoid-based formulations for cancer-related skin indications, including CTCL (Sezary, mycosis fungoides) and actinic keratosis; it has discovered at least two patented cannabinoid combinations and is progressing them through early clinical development with manufacturing and development partnerships, but no pivotal or late‑stage trial results have yet been reported publicly[1][2][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedC Biopharma.